Integrated Diagnostics Holdings (IDHC) Stock Statistics & Valuation Metrics

Integrated Diagnostics Holdings has a market cap or net worth of $325.54M. The enterprise value is ―.

Integrated Diagnostics Holdings has 581,326,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Integrated Diagnostics Holdings’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 20.67%.

The current PE Ratio of Integrated Diagnostics Holdings is 16.3. Integrated Diagnostics Holdings’s PEG ratio is ―.

In the last 12 months, Integrated Diagnostics Holdings had revenue of 7.86B and earned 1.26B in profits. Earnings per share was 2.17.

In the last 12 months, operating cash flow was 1.51B and capital expenditures -251.70M, giving a free cash flow of 1.26B billion.

Integrated Diagnostics Holdings pays an annual dividend of $0.017, resulting in a dividend yield of 2.39%

Integrated Diagnostics Holdings upcoming earnings date is Jun 3, 2026, TBA (Confirmed).

Integrated Diagnostics Holdings as a current ratio of 1.46, with Debt / Equity ratio of 43.40%

In the past 12 months, Integrated Diagnostics Holdings has paid 816.89M in taxes.

Integrated Diagnostics Holdings EV to EBITDA ratio is 7.12, with an EV/FCF ratio of 14.88.

Integrated Diagnostics Holdings has $1.74B in cash and marketable securities with ― in debt, giving a net cash position of $387.90M billion.

Gross margin is 41.09%, with operating margin of 27.05%, and net profit margin of 16.07%.

The average price target for Integrated Diagnostics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―